Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Mutli-center, Open Lable, Single Arm Study to Evaluate the Safety and Effectiveness of Cingularbio® Heart Valve in Aortic/Mitral Valve Replacement Patients

NCT02755220 is registered in ClinicalTrials.gov with Shanghai Cingularbio Co. Ltd as lead sponsor.

NCT NCT02755220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02755220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Mutli-center, Open Lable, Single Arm Study to Evaluate the Safety and Effectiveness of Cingularbio® Heart Valve in Aortic/Mitral Valve Replacement Patients
Lead sponsor
Shanghai Cingularbio Co. Ltd
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2016
Completion date
April 30, 2019
Enrollment
197 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diseases of mitral and aortic valves